Arbutus Biopharma Corp ( ABUS) - Stock Earnings
ABUS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 10, 2026 BeforeMarket | -0.04 / — | — | 299000 / — | — |
ABUS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | 169.7 million USD | 179.1 million USD |
| 2026Q2 | -5.1 million USD | 1.0 million USD |
| 2026Q3 | 59.1 million USD | 299000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ABUS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -72.8 million USD | 18.1 million USD |
| 2024 | -69.9 million USD | 6.2 million USD |
| 2025 | -33.5 million USD | 14.1 million USD |
| 2026 Est. | — | — |
ABUS
Price: $4.08
Earnings Per Share: 1.12 USD
P/E Ratio: 3.46
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 545700
Ebitda: -10.9 millionMarket Capitalization: 594.8 million